ASW

N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide

Created:2012-07-25
Last modified:  2021-03-01

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count47
Chiral Atom Count0
Bond Count50
Aromatic Bond Count22
2D diagram of ASW

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Toggle HydrogenToggle Labels

Chemical Component Summary

NameN-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide
SynonymsAmsacrine
Systematic Name (OpenEye OEToolkits)N-[4-(acridin-9-ylamino)-3-methoxy-phenyl]methanesulfonamide
FormulaC21 H19 N3 O3 S
Molecular Weight393.459
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESACDLabs12.01O=S(=O)(Nc1ccc(c(OC)c1)Nc2c4c(nc3c2cccc3)cccc4)C
SMILESCACTVS3.370COc1cc(N[S](C)(=O)=O)ccc1Nc2c3ccccc3nc4ccccc24
SMILESOpenEye OEToolkits1.7.6COc1cc(ccc1Nc2c3ccccc3nc4c2cccc4)NS(=O)(=O)C
Canonical SMILESCACTVS3.370 COc1cc(N[S](C)(=O)=O)ccc1Nc2c3ccccc3nc4ccccc24
Canonical SMILESOpenEye OEToolkits1.7.6 COc1cc(ccc1Nc2c3ccccc3nc4c2cccc4)NS(=O)(=O)C
InChIInChI1.03 InChI=1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23)
InChIKeyInChI1.03 XCPGHVQEEXUHNC-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB00276 
NameAmsacrine
Groups
  • approved
  • investigational
DescriptionAminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects.
Synonyms
  • 4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide
  • Acridinyl anisidide
  • Amsacrine gluconate
  • Amsacrine hydrochloride
  • Amsacrine
Brand NamesAmsa Pd
IndicationFor treatment of acute myeloid leukaemia.
Categories
  • Acridines
  • Aminoacridines
  • Antineoplastic Agents
  • Antineoplastic and Immunomodulating Agents
  • Cardiotoxic antineoplastic agents
ATC-CodeL01XX01
CAS number51264-14-3

Drug Targets

NameTarget SequencePharmacological ActionActions
DNA-unknownintercalation
DNA topoisomerase 2-betaMAKSGGCGAGAGVGGGNGALTWVTLFDQNNAAKKEESETANKNDSSKKLS...unknowninhibitor
DNA topoisomerase 2-alphaMEVSPLQPVNENMQVNKIKKNEDAKKRLSVERIYQKKTQLEHILLRPDTY...unknowninhibitor
Voltage-gated inwardly rectifying potassium channel KCNH2MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCE...unknowninhibitor
Alpha-1-acid glycoprotein 1MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDRITGKWFYIASAF...unknown
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL43
PubChem 2179
ChEMBL CHEMBL43
ChEBI CHEBI:2687
CCDC/CSD CIRTIG, CIRTIG01, ACRMSA